The DOI matches its Crossref record; 420 of the 420 references it cites were found in a registry or an index.
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Open accessAbstract
TAR DNA binding protein 43 (TDP-43) is a versatile RNA/DNA binding protein involved in RNA-related metabolism. Hyper-phosphorylated and ubiquitinated TDP-43 deposits as inclusion bodies in the brain and spinal cord of the patients with the motor neuron diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). While majority of the ALS cases (90-95%) are sporadic (sALS), among the familial ALS cases 5-10% involve the inheritance of mutations in the TARDBP gene and the remaining (90-95%) are due to mutations in other genes such as: C9ORF72, SOD1, FUS, and NEK1 etc. Strikingly however, majority of the sporadic ALS patients (up to 97%) also contain the TDP-43 protein deposited in the neuronal inclusions, which suggests of its pivotal role in the ALS pathology. Thus, unravelling the molecular mechanisms of the TDP-43 pathology, seems central to the ALS therapeutics, hence, we comprehensively review the current understanding of the TDP-43’s pathology in ALS. We discuss the roles of TDP-43’s mutations, its cytoplasmic mis-localization and aberrant post-translational modifications in ALS. Also, we evaluate TDP-43’s amyloid-like in vitro aggregation, its physiological versus pathological oligomerization in vivo, liquid-liquid phase separation (LLPS), and potential prion-like propagation propensity of the TDP-43 inclusions. Finally, we describe the various evolving TDP-43-induced toxicity mechanisms such as the impairment of endocytosis and mitotoxicity etc. and also discuss the emerging strategies towards TDP-43 disaggregation and ALS therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–420 of 420
Chromatin regulation in complex brain disorders
Bastle, R. M., & Maze, I. S. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.07.004 · Cited by 33
Yamashita, S., Kimura, E., Tawara, N., Sakaguchi, H., Nakama, T., Maeda, Y., Hirano, T., Uchino, M., & Ando, Y. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01297.x · Cited by 31
Cassel, J. A., McDonnell, M. E., Velvadapu, V., Andrianov, V., & Reitz, A. B. (2012) · Biochimie · doi:10.1016/j.biochi.2012.05.020 · Cited by 31
Lü, Y., Tang, C., Zhu, L., Li, J., Liang, H., Zhang, J., & Xu, R. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.15938 · Cited by 31
Detection of TDP‐43 oligomers in frontotemporal lobar degeneration–TDP
Kao, P. F., Chen, Y., Liu, X., DeCarli, C. S., Seeley, W. W., & Jin, L. (2015) · Annals of Neurology · doi:10.1002/ana.24431 · Cited by 30
Bäumer, D., Parkinson, N., & Talbot, K. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.166512 · Cited by 30
Wobst, H. J., Delsing, L., Brandon, N. J., & Moss, S. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177181 · Cited by 29
Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
Hammam, K., Sáez‐Ayala, M., Rebuffet, E., Gros, L., Lopez, S., Hajem, B., Humbert, M., Baudelet, É., Audebert, S., Betzi, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01582-5 · Cited by 28
Kabuta, C., Kono, K., Wada, K., & Kabuta, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.027 · Cited by 27
Higashi, S., Tsuchiya, Y., Araki, T., Wada, K., & Kabuta, T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.09.010 · Cited by 27
Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins
Braun, R. J. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00008 · Cited by 27
Araki, W., Minegishi, S., Motoki, K., Kume, H., Hohjoh, H., Araki, Y. M., & Tamaoka, A. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8644-6 · Cited by 27
Tian, Y., Che, F. Y., Su, Q., Lu, Y., You, C., Huang, L. M., Wang, S., Wang, L., & Yu, J. (2017) · Genetics and Molecular Research · doi:10.4238/gmr16029638 · Cited by 26
Glutathione monoethyl ester prevents TDP-43 pathology in motor neuronal NSC-34 cells
Chen, T., Turner, B. J., Beart, P. M., Sheehan-Hennessy, L., Elekwachi, C., & Muyderman, H. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.009 · Cited by 22
Janssens, J., Kleinberger, G., Wils, H., & Broeckhoven, C. V. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390954 · Cited by 18
Glutamate and ATP: The Crossroads of Signaling and Metabolism in the Brain
Verkhratsky, A., Schousboe, A., & Parpura, V. (2014) · Advances in neurobiology · doi:10.1007/978-3-319-08894-5_1 · Cited by 12
PRO-MINE: A Bioinformatics Repository and Analytical Tool for TARDBP Mutations
Pinto, S., Vlahoviček, K., & Buratti, E. (2010) · Human Mutation · doi:10.1002/humu.21393 · Cited by 10
TDP-43 overexpression impairs presynaptic integrity
Moussa, C.-H., & Heyburn, L. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.195272 · Cited by 10
Kitamura, A., Yuno, S., Muto, H., & Kinjo, M. (2017) · Genes to Cells · doi:10.1111/gtc.12495 · Cited by 10
A neurodegenerative-disease protein forms beneficial aggregates in healthy muscle
Becker, L. A., & Gitler, A. D. (2018) · Nature · doi:10.1038/d41586-018-07141-2 · Cited by 6
Cited by
PINK1/Parkin-mediated mitophagy in neurodegenerative diseases
Li, J., Yang, D., Li, Z., Zhao, M., Wang, D., Sun, Z., Wen, P., Dai, Y., Gou, F., Ji, Y., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101817 · Cited by 383
TDP-43 proteinopathies: a new wave of neurodegenerative diseases
de Boer, E. M. J., Orie, V. K., Williams, T., Baker, M. R., De Oliveira, H. M., Polvikoski, T., Silsby, M., Menon, P., van den Bos, M., Halliday, G. M., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-322983 · Cited by 381
The Role of Oxidative Stress in Parkinson’s Disease
Chang, K.-H., & Chen, C.-M. (2020) · Antioxidants · doi:10.3390/antiox9070597 · Cited by 341
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Cohen, J., Mathew, A., Dourvetakis, K. D., Sanchez-Guerrero, E., Pangeni, R. P., Gurusamy, N., Aenlle, K. K., Ravindran, G., Twahir, A., Isler, D., et al. (2024) · Cells · doi:10.3390/cells13060511 · Cited by 103
“The cytoplasmic mislocalization and aggregation of TDP-43 is a major pathological hallmark for sporadic ALS [204,205].”
BackgroundGarcia Morato, J., Hans, F., von Zweydorf, F., Feederle, R., Elsässer, S. J., Skodras, A. A., Gloeckner, C. J., Buratti, E., Neumann, M., & Kahle, P. J. (2022) · Nature Communications · doi:10.1038/s41467-022-28822-7 · Cited by 94
Metadata
- Authors
- Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., & Patel, B. K.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-02-14
- Volume
- 12
- Pages
- 25-25
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2911237161
- Cited by
- 774
- References
- 420
- FWCI
- 47.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.